Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Experimental Pharmacology and Drug Discovery

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1711917

Ultrafine garlic powder alleviates non-alcoholic steatohepatitis by inhibiting hepatocyte ferroptosis and modulating ERK-dependent oxidative stress

Provisionally accepted
Junhui  YuJunhui Yu1Ningning  ShaoNingning Shao1Jianming  YangJianming Yang1Long  YangLong Yang1Kaiwen  HongKaiwen Hong1Yuzhu  ChenYuzhu Chen1Xiaoming  ZhaoXiaoming Zhao2Hongzhi  YuHongzhi Yu1涛  张涛 张3Jinrui  DongJinrui Dong1*
  • 1Tianjin University, Tianjin, China
  • 2Lafayette College, Easton, United States
  • 3School of Materials Science and Engineering, Beihang University,, Beijing, China

The final, formatted version of the article will be published soon.

Nonalcoholic steatohepatitis (NASH) is a chronic liver disease associated with 33 oxidative stress and ferroptosis, leading to liver injury and fibrosis. Garlic, 34 renowned for its antioxidant and hepatoprotective properties, is commonly 35 used in traditional medicine. Ultrafine powder technology enhances the 36 physicochemical properties of natural products, improving their bioavailability 37 and efficacy. This study explores the protective effects of ultrafine garlic 38 powder (UGP) on NASH and its underlying mechanisms.In this study, UGP 39 was prepared by high-speed particle collision technology and compared with 40 traditional garlic powder (TGP). UGP exhibited a particle size (d(0.5) of 41 approximately 4 µm) that is 30 times smaller than TGP, showing significantly 42 smaller particle size and lower contact angle (UGP=59.775°vs TGP=83.545°). 43 UGP also demonstrated improved solubility and dispersibility, along with an 44 enrichment of key organosulfur compounds such as allicinAllicin, Alliin, SAC, 45 and GSAC. In vitro, UGP significantly reduced palmitic acid-induced ROS 46 production (n=4, p< 0.0001), prevented mitochondrial dysfunction (n=4, 47 p=0.0035), and thereby reduced hepatic stellate cell activation. UGP lowered 48 intracellular Fe2+ levels in hepatocytes from 68.72% to 34.48% (n=4) and 49 significantly protected hepatocytes from erastin-induced ferroptosis (cell 50 viability: UGP treatment 23.46% vs erastin stimulation 53.91%, n = 4, p 51 <0.0001).In the acute liver fibrosis model induced by methionine-and 52 choline-deficient diet supplemented with 60 kcal% fat (CDHF), UGP

Keywords: Ultrafine powder, NASH, hepatocyte, ferroptosis, Fibrosis, ROS

Received: 24 Sep 2025; Accepted: 20 Oct 2025.

Copyright: © 2025 Yu, Shao, Yang, Yang, Hong, Chen, Zhao, Yu, 张 and Dong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jinrui Dong, jinrui_dong@tju.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.